aluates Reports

$ 0.0

Automative

Global CRISPR-Based Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-35K14121

Global CRISPR Based Therapeutics Market Research Report 2023

BUY CHAPTERS

Global CRISPR-Based Therapeutics Market Research Report 2025

Code: QYRE-Auto-35K14121

Report

September 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Caribou Biosciences

Addgene

CRISPR Therapeutics

Merck KGaA

Mirus Bio LLC

Editas Medicine

Takara Bio USA

Thermo Fisher Scientific

Horizon Discovery Group

Intellia Therapeutics

GE Healthcare Dharmacon

CRISPR-Based Therapeutics Market

The global market for CRISPR-Based Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases.

North American market for CRISPR-Based Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for CRISPR-Based Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for CRISPR-Based Therapeutics in Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of CRISPR-Based Therapeutics include Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CRISPR-Based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR-Based Therapeutics.

The CRISPR-Based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR-Based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRISPR-Based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CRISPR-Based Therapeutics Market Report

Report Metric	Details
Report Name	CRISPR-Based Therapeutics Market
Segment by Type	Genome Editing Genetic Engineering gRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering
Segment by Application	Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, GE Healthcare Dharmacon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR-Based Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CRISPR-Based Therapeutics Market report?

Ans: The main players in the CRISPR-Based Therapeutics Market are Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, GE Healthcare Dharmacon

What are the Application segmentation covered in the CRISPR-Based Therapeutics Market report?

Ans: The Applications covered in the CRISPR-Based Therapeutics Market report are Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes

What are the Type segmentation covered in the CRISPR-Based Therapeutics Market report?

Ans: The Types covered in the CRISPR-Based Therapeutics Market report are Genome Editing, Genetic Engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genome Editing

1.2.3 Genetic Engineering

1.2.4 gRNA Database/Gene Librar

1.2.5 CRISPR Plasmid

1.2.6 Human Stem Cells

1.2.7 Genetically Modified Organisms/Crops

1.2.8 Cell Line Engineering

1.3 Market by Application

1.3.1 Global CRISPR-Based Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biotechnology Companies

1.3.3 Pharmaceutical Companies

1.3.4 Academic Institutes

1.3.5 Research and Development Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRISPR-Based Therapeutics Market Perspective (2020-2031)

2.2 Global CRISPR-Based Therapeutics Growth Trends by Region

2.2.1 Global CRISPR-Based Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CRISPR-Based Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 CRISPR-Based Therapeutics Market Dynamics

2.3.1 CRISPR-Based Therapeutics Industry Trends

2.3.2 CRISPR-Based Therapeutics Market Drivers

2.3.3 CRISPR-Based Therapeutics Market Challenges

2.3.4 CRISPR-Based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRISPR-Based Therapeutics Players by Revenue

3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2020-2025)

3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CRISPR-Based Therapeutics Revenue

3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio

3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2024

3.5 Global Key Players of CRISPR-Based Therapeutics Head office and Area Served

3.6 Global Key Players of CRISPR-Based Therapeutics, Product and Application

3.7 Global Key Players of CRISPR-Based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR-Based Therapeutics Breakdown Data by Type

4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2026-2031)

5 CRISPR-Based Therapeutics Breakdown Data by Application

5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CRISPR-Based Therapeutics Market Size (2020-2031)

6.2 North America CRISPR-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CRISPR-Based Therapeutics Market Size by Country (2020-2025)

6.4 North America CRISPR-Based Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRISPR-Based Therapeutics Market Size (2020-2031)

7.2 Europe CRISPR-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CRISPR-Based Therapeutics Market Size by Country (2020-2025)

7.4 Europe CRISPR-Based Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific CRISPR-Based Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CRISPR-Based Therapeutics Market Size (2020-2031)

9.2 Latin America CRISPR-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CRISPR-Based Therapeutics Market Size by Country (2020-2025)

9.4 Latin America CRISPR-Based Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa CRISPR-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Caribou Biosciences

11.1.1 Caribou Biosciences Company Details

11.1.2 Caribou Biosciences Business Overview

11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction

11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.1.5 Caribou Biosciences Recent Development

11.2 Addgene

11.2.1 Addgene Company Details

11.2.2 Addgene Business Overview

11.2.3 Addgene CRISPR-Based Therapeutics Introduction

11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.2.5 Addgene Recent Development

11.3 CRISPR THERAPEUTICS

11.3.1 CRISPR THERAPEUTICS Company Details

11.3.2 CRISPR THERAPEUTICS Business Overview

11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction

11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.3.5 CRISPR THERAPEUTICS Recent Development

11.4 Merck KGaA

11.4.1 Merck KGaA Company Details

11.4.2 Merck KGaA Business Overview

11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction

11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.4.5 Merck KGaA Recent Development

11.5 Mirus Bio LLC

11.5.1 Mirus Bio LLC Company Details

11.5.2 Mirus Bio LLC Business Overview

11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction

11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.5.5 Mirus Bio LLC Recent Development

11.6 Editas Medicine

11.6.1 Editas Medicine Company Details

11.6.2 Editas Medicine Business Overview

11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction

11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.6.5 Editas Medicine Recent Development

11.7 Takara Bio USA

11.7.1 Takara Bio USA Company Details

11.7.2 Takara Bio USA Business Overview

11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction

11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.7.5 Takara Bio USA Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Details

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction

11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Horizon Discovery Group

11.9.1 Horizon Discovery Group Company Details

11.9.2 Horizon Discovery Group Business Overview

11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction

11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.9.5 Horizon Discovery Group Recent Development

11.10 Intellia Therapeutics

11.10.1 Intellia Therapeutics Company Details

11.10.2 Intellia Therapeutics Business Overview

11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction

11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.10.5 Intellia Therapeutics Recent Development

11.11 GE Healthcare Dharmacon

11.11.1 GE Healthcare Dharmacon Company Details

11.11.2 GE Healthcare Dharmacon Business Overview

11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction

11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2020-2025)

11.11.5 GE Healthcare Dharmacon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Caribou Biosciences

Addgene

CRISPR Therapeutics

Merck KGaA

Mirus Bio LLC

Editas Medicine

Takara Bio USA

Thermo Fisher Scientific

Horizon Discovery Group

Intellia Therapeutics

GE Healthcare Dharmacon

List of Tables

Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genome Editing

Table 3. Key Players of Genetic Engineering

Table 4. Key Players of gRNA Database/Gene Librar

Table 5. Key Players of CRISPR Plasmid

Table 6. Key Players of Human Stem Cells

Table 7. Key Players of Genetically Modified Organisms/Crops

Table 8. Key Players of Cell Line Engineering

Table 9. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global CRISPR-Based Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global CRISPR-Based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global CRISPR-Based Therapeutics Market Share by Region (2020-2025)

Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global CRISPR-Based Therapeutics Market Share by Region (2026-2031)

Table 15. CRISPR-Based Therapeutics Market Trends

Table 16. CRISPR-Based Therapeutics Market Drivers

Table 17. CRISPR-Based Therapeutics Market Challenges

Table 18. CRISPR-Based Therapeutics Market Restraints

Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global CRISPR-Based Therapeutics Market Share by Players (2020-2025)

Table 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2024)

Table 22. Ranking of Global Top CRISPR-Based Therapeutics Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of CRISPR-Based Therapeutics, Headquarters and Area Served

Table 25. Global Key Players of CRISPR-Based Therapeutics, Product and Application

Table 26. Global Key Players of CRISPR-Based Therapeutics, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2020-2025)

Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2026-2031)

Table 32. Global CRISPR-Based Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2020-2025)

Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2026-2031)

Table 36. North America CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America CRISPR-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America CRISPR-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe CRISPR-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe CRISPR-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific CRISPR-Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America CRISPR-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America CRISPR-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 51. Caribou Biosciences Company Details

Table 52. Caribou Biosciences Business Overview

Table 53. Caribou Biosciences CRISPR-Based Therapeutics Product

Table 54. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Caribou Biosciences Recent Development

Table 56. Addgene Company Details

Table 57. Addgene Business Overview

Table 58. Addgene CRISPR-Based Therapeutics Product

Table 59. Addgene Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Addgene Recent Development

Table 61. CRISPR THERAPEUTICS Company Details

Table 62. CRISPR THERAPEUTICS Business Overview

Table 63. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product

Table 64. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 65. CRISPR THERAPEUTICS Recent Development

Table 66. Merck KGaA Company Details

Table 67. Merck KGaA Business Overview

Table 68. Merck KGaA CRISPR-Based Therapeutics Product

Table 69. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Merck KGaA Recent Development

Table 71. Mirus Bio LLC Company Details

Table 72. Mirus Bio LLC Business Overview

Table 73. Mirus Bio LLC CRISPR-Based Therapeutics Product

Table 74. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Mirus Bio LLC Recent Development

Table 76. Editas Medicine Company Details

Table 77. Editas Medicine Business Overview

Table 78. Editas Medicine CRISPR-Based Therapeutics Product

Table 79. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Editas Medicine Recent Development

Table 81. Takara Bio USA Company Details

Table 82. Takara Bio USA Business Overview

Table 83. Takara Bio USA CRISPR-Based Therapeutics Product

Table 84. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Takara Bio USA Recent Development

Table 86. Thermo Fisher Scientific Company Details

Table 87. Thermo Fisher Scientific Business Overview

Table 88. Thermo Fisher Scientific CRISPR-Based Therapeutics Product

Table 89. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Thermo Fisher Scientific Recent Development

Table 91. Horizon Discovery Group Company Details

Table 92. Horizon Discovery Group Business Overview

Table 93. Horizon Discovery Group CRISPR-Based Therapeutics Product

Table 94. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Horizon Discovery Group Recent Development

Table 96. Intellia Therapeutics Company Details

Table 97. Intellia Therapeutics Business Overview

Table 98. Intellia Therapeutics CRISPR-Based Therapeutics Product

Table 99. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 100. Intellia Therapeutics Recent Development

Table 101. GE Healthcare Dharmacon Company Details

Table 102. GE Healthcare Dharmacon Business Overview

Table 103. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product

Table 104. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 105. GE Healthcare Dharmacon Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. CRISPR-Based Therapeutics Picture

Figure 2. Global CRISPR-Based Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CRISPR-Based Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Genome Editing Features

Figure 5. Genetic Engineering Features

Figure 6. gRNA Database/Gene Librar Features

Figure 7. CRISPR Plasmid Features

Figure 8. Human Stem Cells Features

Figure 9. Genetically Modified Organisms/Crops Features

Figure 10. Cell Line Engineering Features

Figure 11. Global CRISPR-Based Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global CRISPR-Based Therapeutics Market Share by Application: 2024 VS 2031

Figure 13. Biotechnology Companies Case Studies

Figure 14. Pharmaceutical Companies Case Studies

Figure 15. Academic Institutes Case Studies

Figure 16. Research and Development Institutes Case Studies

Figure 17. CRISPR-Based Therapeutics Report Years Considered

Figure 18. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global CRISPR-Based Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global CRISPR-Based Therapeutics Market Share by Region: 2024 VS 2031

Figure 21. Global CRISPR-Based Therapeutics Market Share by Players in 2024

Figure 22. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2024

Figure 24. North America CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America CRISPR-Based Therapeutics Market Share by Country (2020-2031)

Figure 26. United States CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe CRISPR-Based Therapeutics Market Share by Country (2020-2031)

Figure 30. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2020-2031)

Figure 38. China CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America CRISPR-Based Therapeutics Market Share by Country (2020-2031)

Figure 46. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2020-2031)

Figure 50. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE CRISPR-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 54. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 55. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 56. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 57. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 58. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 59. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 61. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 62. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 63. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CRISPR Gene Editing Tools Market Research Report 2024

Global CRISPR Gene Editing Market Research Report 2024

Global Crispr Genomic Cure Market Research Report 2024

Global CRISPR Editing Platform Market Research Report 2024

Global CRISPR Cell Line Development Market Research Report 2024

Global Gene Editing Technologies Market Insights Forecast to 2030

Global Gene Editing Technology Market Research Report 2024

Global Genome Editing Techniques Market Research Report 2024

Global CRISPR associated Nucleases Market Research Report 2024

Global Gene Editing Technology Innovation Platform Market Research Report 2024

Global Gene Editing Therapy Market Research Report 2024

Global CRISPR PE Technology Market Research Report 2024

Global Gene Editing Drug Market Research Report 2024

Global CRISPR Gene Editing Service Market Research Report 2025

Global CRISPR Gene Testing and Diagnostics Market Research Report 2024

CRISPR in Agriculture Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Nucleases Market Research Report 2024

Global CRISPR Gene Detection and Diagnostic Market Research Report 2024

Global CRISPR Cas9 Gene Editing Service Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions